Anticholinergic Agents Long-Acting (Inhaled)

Inhaled long-acting anticholinergic agents, commonly known as long-acting muscarinic antagonists (LAMAs), are a class of maintenance bronchodilators administered by oral inhalation

Inhaled long-acting anticholinergic agents, commonly known as long-acting muscarinic antagonists (LAMAs), are a class of maintenance bronchodilators administered by oral inhalation They work by competitively binding to and inhibiting muscarinic (primarily M3) receptors on airway smooth muscle, which blocks acetylcholine-mediated parasympathetic bronchoconstriction to produce prolonged airway relaxation and reduce airflow obstruction These agents—including tiotropium, umeclidinium, glycopyrrolate...

Inhaled long-acting anticholinergic agents, commonly known as long-acting muscarinic antagonists (LAMAs), are a class of maintenance bronchodilators administered by oral inhalation

They work by competitively binding to and inhibiting muscarinic (primarily M3) receptors on airway smooth muscle, which blocks acetylcholine-mediated parasympathetic bronchoconstriction to produce prolonged airway relaxation and reduce airflow obstruction

They work by competitively binding to and inhibiting muscarinic (primarily M3) receptors on airway smooth muscle, which blocks acetylcholine-mediated parasympathetic bronchoconstriction to produce prolonged airway relaxation and reduce airflow obstruction These agents—including tiotropium, umeclidinium, glycopyrrolate, and aclidinium—are primarily indicated for the long-term maintenance management of chronic obstructive pulmonary disease (COPD) and, for select formulations, as add-on maintenance...

These agents—including tiotropium, umeclidinium, glycopyrrolate, and aclidinium—are primarily indicated for the long-term maintenance management of chronic obstructive pulmonary disease (COPD) and, for select formulations, as add-on maintenance therapy in moderate-to-severe persistent asthma